1-66372630-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002600.4(PDE4B):āc.2163G>Cā(p.Glu721Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,613,934 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002600.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDE4B | NM_002600.4 | c.2163G>C | p.Glu721Asp | missense_variant | 17/17 | ENST00000341517.9 | NP_002591.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDE4B | ENST00000341517.9 | c.2163G>C | p.Glu721Asp | missense_variant | 17/17 | 1 | NM_002600.4 | ENSP00000342637 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000156 AC: 39AN: 250660Hom.: 2 AF XY: 0.0000738 AC XY: 10AN XY: 135422
GnomAD4 exome AF: 0.0000280 AC: 41AN: 1461714Hom.: 1 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727144
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2022 | The c.2163G>C (p.E721D) alteration is located in exon 17 (coding exon 16) of the PDE4B gene. This alteration results from a G to C substitution at nucleotide position 2163, causing the glutamic acid (E) at amino acid position 721 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at